Is there an article or other item that you think should be added in
this section?
Please send your suggestions to: info@treeage.com.
Examples of Healthcare-Related Modeling using TreeAge Software
Aggarwal R, Ghoshal UC, Naik SR. Assessment of cost-effectiveness of universal hepatitis B immunization in a low-income country with intermediate endemicity using a Markov model. J Hepatol. 2003 Feb; 38:215-22.
[77]
Aggarwal R, Ghoshal UC, Naik SR. Treatment of chronic hepatitis B with
interferon-alpha: cost-effectiveness in developing countries. Natl Med J India. 2002 Nov-Dec;15(6):320-7.
[81]
Albert, D.A., Aksentijevich, S., Hurst, S., Fries, J.F., Wolfe, F. "Modeling Therapeutic Strategies in Rheumatoid Arthritis: Use of Decision Analysis and Markov Models" Jour Rheum 27(3):644-652 (2000) [3]
Anderson, Robert. UK Department of Health
"Discounting future health benefits: Should hepatitis B immunisation be expected to survive the Treasurys 6% discount rate?."
Institute of Public Health, Cambridge (workshop)
(1998).
* link to full-text:
http://www.medinfo.cam.ac.uk/com_med/cambhealthfora/forum%201%20summary.rtf [25]
Baker GM, Martin JE, Jang R, Myre SA, Armitstead JA, Schroeder TJ, First MR.
"Pharmacokinetic Analysis Of Mycoprenolate Mofetil Versus Azathioprine In Cadaveric Renal Transplantation."
Amer Soc Trans (abstract)
* link to full-text:
http://www.a-s-t.org/abstracts98/213.htm [26]
Barry, H.C., Ebell, M.H.,
Hickner, J. "Evalution of Suspected Urinary Tract Infection
in Ambulatory Women: A Cost-Utility Analysis of Office-Based
Strategies" Jour Fam Prac 44(1):49-60 (1997). [27]
Briggs, A.H.,
M.J. Sculpher, R.P.H. Logan, J. Aldous, M.E. Ramsey, J.H.
Baron. "Cost Effectiveness of Screening for and
Eradication of Helicobacter Pylori in Management of
Dyspeptic Patients under 45 Years of Age." BMJ
312:1321 (1996) [29]
Catherwood, E.,
Fitzpatrick, W.D., Greenberg, M.L., Holzberger, P.T.,
Malenka, D.J., Gerling, B.R., Birkmeyer, J.D. "Cost-Effectiveness
of Cardioversion and Antiarrhythmic Therapy in Nonvalvular Atrial
Fibrilliation" Ann Int Med 130(8):625-636 (1999) [31]
Chancellor, J.V.,
Hill, A.M., Sabin, C.A., Simpson, K.N., Youle, M. "Modelling
the Cost Effectiveness of Lamivudine/Zidovudine Combination
Therapy in HIV Infection." Pharmacoeconomics
Jul., 12(1):54-66 (1997). [32]
Conners GP. "A
literature-based comparison of three methods of pediatric esophageal
coin removal." Pediatric Emergency Care 13:154-157
(1997).
* link to abstract:
http://www.york.ac.uk/inst/crd [33]
Craig J. Wilson, MBBS, and Santanu K. Datta, MS, MBA.
"Tai Chi for the Prevention of Fractures in a Nursing Home Population: An Economic Analysis."
JCOM
8, 3:19-28 (2001).
* link to full-text:
http://www.turner-white.com/pdf/jcom_mar01_taichi.pdf [64]
Cromwell, David. M., Richard D. Moore, Jill D.
Brensinger, Gloria M. Petersen, Eric
B. Bass, Francis M. Giardiello. "Cost
Analysis of Alternative Approaches to Colorectal Screening in
Familial Adenomatous Polyposis." Gastroenterology 114:893-901 (1998). [34]
Elena Losina, PhD, et al,
"Cost-effectiveness of Total Knee Arthroplasty in the United States: Patient Risk and Hospital Volume." Arch of Internal Medicine 2009;169(12):1113-1121.
* link to abstract: http://archinte.ama-assn.org/cgi/content/short/169/12/1113 [105]
Ernst, Frank R., Amy J. Grizzle.
"Drug-Related Morbidity and Mortality: Updating the Cost-of-Illness Model."
Jour Am Pharm Assoc
41, 2:192-199 (2001).
* link to full-text:
http://www.aphanet.org/news/Ernst.PDF [36]
Fass, Ronnie, M. Brian Finnerty, Joshua J.
Ofman, Ian M. Granlek, Cynthia Johnson, Elizabeth Camargo, Richard
E. Sampliner.
"Clinical and Economic Value of a
Short Course of Omeprazole in Patients with Non-Cardiac
Chest Pain (NCCP)." Gastroenterology 115:42-49
(1998). [37]
Fiscella, Kevin
and Peter Franks. "Cost-Effectiveness of the
Transdermal Nicotine Patch as an Adjunct to Physicians
Smoking Cessation Counseling." JAMA 275:1247 (1996). [38]
Gambhir SS, Hoh CK, Phelps ME, Madar I, Maddahi J. "Decision Tree Sensitivity Analysis for Cost Effectiveness of FDG PET in the Staging and Management of Non-Small Cell Lung Carcinoma." J Nucl Med; 37(9): 1428-1436 (1996). [39]
Garber,
Alan M., Neil A. Solomon. "Cost-Effectiveness
of Alternative Test Strategies for the Diagnosis of
Coronary Artery Disease." Annals of Internal Medicine 130:719-728
(1999).
* link to full-text:http://www.acponline.org/journals/annals/04may99/garber.htm [40]
Goffin, J. R. and D. Tu, "Phase II stopping rules employing response rates and early progression" Jour Clin Oncol, 2007 ASCO Annual Meeting Proceedings, 25(18S, June 20 Supplement): 2553 (2007).
[103]
Grill, Eva, Franz Hessel, Uwe Siebert, Petra Schnell-Inderst, Silke Kunze, Andreas Nickisch, and Jürgen Wasem. "Comparing the clinical effectiveness of different new-born hearing screening strategies. A decision analysis." BMC Public Health 2005, 5:12
http://www.biomedcentral.com/1471-2458/5/12 [90]
Groeneveld, Peter W., MD; Jeanne L. Kwong, MBA; Yueyi Liu, MS; Adam J. Rodriguez, MBA; Michael P. Jones, MBA; Gillian D. Sanders, PhD; Alan M. Garber, MD, PhD. "Cost-effectiveness of Automated External Defibrillators on Airlines." JAMA 286:1482-1489 (2001).
* link to full-text:http://www-smi.stanford.edu/pubs/SMI_Reports/SMI-2001-0893.pdf
[41]
Hallan, Stein, A. Asberg,
B. Indredavik, T. E. Wideroe. "A Decision Analysis of Thrombolytic Therapy
Compared with Standard Therapy in Acute Ischaemic Stroke"
Journal of Internal Medicine 246:549-559 (1999). [42]
Hamm,Robert
M. , Vickie Loemker, Kathryn
L. Reilly, Gary Johnson, Peggy Dubois, Kathleen
Staveley-OCarroll, James Brand, Tomas Owens, and Kenneth Smit. "Clinical
Decision Analysis of Cryotherapy Compared to Expectant Management
for Mild Cervical Dysplasia." Journal of Family
Practice 47(3):193-201 (1998).
* link to full-text:http://www.fammed.ouhsc.edu/RobHamm/mcd4/cervdysp.html [43]
Holmberg, Hakan, Per Carlsson, Owe Lofman,
Eberhard Varenhorst "Economic Evaluation of Screening for
Prostate Cancer: a Randomized Population
Based Programme During a 10-year Period in Sweden."
Health Policy 45:133-147 (1998) [44]
Kemper, Alex R., W. Clayton Bordley, Stephen
M. Downs. "Cost-effectiveness Analysis
of Lead Poisoning Screening Strategies Following
the 1997 Guidelines of the Centers for Disease
Control and Prevention." Arch Ped Adol Med 152:1202-1208
(1998). [47]
Kevin J. Inman, MSc; Kate Dymock, RN; Nancy Fysh, RN; Beth Robbins, RN; Frank S. Rutledge, MD; and William J. Sibbald, MD.
"Pressure Ulcer Prevention: A Randomized Controlled Trial of 2 Risk-Directed Strategies for Patient Surface Assignment."
Adv Wound Care
12:73-80 (1999).
* link to full-text:
http://www.woundcarenet.com/advances/articles/99march_pressure.htm [46]
Lee, Stephanie
J., Karen M. Kuntz, Mary M. Horowitz, Philip B. McGlave,
John M. Goldman, Kathleen A. Sobocinski, Janet Hegland,
Craig Kollman, Susan K. Parsons, Milton C. Weinstein,
Jane C. Weeks, Joseph H. Antin, "Unrelated Donor
Bone Marrow Transplantation for Chronic Myelogenous
Leukemia: A Decision Analysis." Annals of
Internal Medicine 127:1080-1089 (1997) [48]
Lee, Tina T.,
Neil A. Solomon, Paul A. Heidenreich, John Oehlert and
Alan M. Garber, "Cost-Effectiveness of Screening for
Carotid Stenosis in Asymptomatic Persons." Annals
of Internal Medicine 126:337-346 (1997)
* link to full-text: http://www.acponline.org/journals/annals/01mar97/stenosis.htm [49]
Lessler, Daniel
S., Sean D. Sullivan, and Andy Stergachis,
"Cost-Effectiveness of Unenhanced MR Imaging vs
Contrast-Enhanced CT of the Abdomen or Pelvis." American
Journal of Radiology 163:5 (1994). [50]
Mamdani,
Muhammed M., Cindy M. Weingarten and James G. Stevenson.
"Thromboemolic Prophylaxis in Moderate-Risk Patients
Undergoing Elective Abdominal Surgery: Decision and
Cost-Effectiveness Analyses." Pharmacotherapy
16:1111 (1996) [69]
Moriguchi, H.,
Kobayashi, M., Tazawa, J., Sato, C.,
"A Decision Analysis of Management Strategies for Polypoid
Lesions of the Gallbladder." SMDM paper
(1999). [68]
Muennig, Peter, Daniel Pallin, Randall L. Sell, Man-Suen Chan. "Cost-Effectiveness of Strategies
for the Treatment of Intestinal Parasites
in Immigrants." NEJM
340(10):773-779 (1999) [52]
Myers, E. R.,
Alvarez, J. G., Richardson, D. K., Ludmir, J.,
"Cost-Effectiveness of Fetal Lung Maturity Testing
in Preterm Labor." Obstetric Gynecology 90:824-9
(1997). [53]
Myers, E. R.,
Thompson, J. W., Simpson, K., "Cost-Effectiveness of
Mandatory Compared with Voluntary Screening for Human
Immunodeficiency Virus in Pregnancy." Obstetric
Gynecology 91:174-81 (1998). [54]
Myers, Evan R. et al,
"Management of Adnexal Mass"
AHRQ/CDC
Evidence Report/Technology Assessment #130,
AHRQ Publication No. 06-E004. 520 pages (2006).
* link to full-text:
www.scribd.com/doc/551191/CDC-Release-adnexal
[104]
O’Connell JM, Brunson D, Anselmo T, Sullivan PW. "Costs and savings associated with community water fluoridation programs in Colorado." Prev Chronic Dis [serial online] 2005 Nov
* link to full-text:
http://www.cdc.gov/pcd/issues/2005/nov/05_0082.htm [87]
Ofman, Joshua
J., Jeff Etchason, Steven Fullerton, Katherine L. Kahn
and Andrew H. Soll, "Management Strategies for
Helicobacter pylori-Seropositive Patients with Dyspepsia:
Clinical and Economic Consequences." Annals of
Internal Medicine 126:280-291 (1997)
* link to full-text:
http://www.acponline.org/journals/annals/15feb97/dyspepsi.htm [55]
Olson, A. D., J. T. Flynn.
"Pre-transplant Varicella Vaccination is Cost-effective in Pediatric Renal Transplantation."
Amer Soc Trans (abstract)
* link to full-text:
http://www.a-s-t.org/abstracts99/694.htm [56]
Orr, Richard K., MD, MPH, James L. Hoehn, MD, MS; Nananda F. Col, MD, MPH, MPP.
"The Learning Curve for Sentinel Node Biopsy in Breast Cancer Practical Considerations."
Arch Surg
134:764-767 (1999).
* link to full-text:
http://www.ama-assn.org/special/womh/library/readroom/arch99/sne8010.htm [57]
Palmer, A. J., P. P. Sendi, G. A. Spinas.
"Applying some UK Prospective Diabetes
Study results to Switzerland:
the cost-effectiveness of intensive
glycaemic control with metformin
versus conventional control in over-weight
patients with type-2 diabetes."
Schweiz Med Wochenschr
130:1034–40 (2000).
* link to full-text:
http://www.smw.ch/pdf/2000_27-28/2000-27-017.PDF [58]
Plans-Rubió P. Critical prevalence of antibodies minimizing vaccination costs for hepatitis A, herpatitis B, varicella, measles and tetanus in Catalonia, Spain. Vaccine 2004; 22:4002-4013. [101]
Robert L. Bree, MD, MHSA, Renee J. Goldberg Arnold, PharmD, Krista G. Pettit, PharmD
Diana J. Kaniecki, PharmD, Christian O’Haeri, PharmD, Norman D. LaFrance, MD, Anna Lev Toaff, MD.
"Use of a Decision-Analytic Model to Support
the Use of a New Oral US Contrast Agent
in Patients with Abdominal Pain ."
Acad Radiol
8:234–242 (2001).
* link to full-text:
http://www.academicradiology.com/AR_2001/Mar01/5c030100234p.PDF [28]
Ruth C. Carlos, MD, MS, Robert L. Bree, MD, MHSA, Paul H. Abrahamse, MA, A. Mark Fendrick, MD.
"Cost-Effectiveness of Saline-assisted
Hysterosonography and Office Hysteroscopy
in the Evaluation of Postmenopausal Bleeding:
A Decision Analysis." Acad Radiol 8:835–844 (2001).
* link to full-text:http://www.academicradiology.com/AR_2001/Sep01/5c090100835p.PDF [30]
Salzmann, Peter;
Karla Kerlikowske, Kathryn Phillips,
"Cost-Effectiveness of Extending Screening
Mammography Guidelines To Include Women 40 to 49 Years of
Age." Annals of Internal Medicine 127:955-965
(1997)
* link to full-text: http://www.acponline.org/journals/annals/01dec97/exscreen.htm [59]
Sheffield,
Reinee E., Sean D. Sullivan, Emmanuel Saltiel, and Lyn
Nishimura, "Cost Comparison of Recombinant Human
Erythropoietin and Blood Transfusion in Cancer
Chemotherapy-Induced Anemia." Annals of
Pharmacotherapy 31:15 (1997). [60]
Simons, G. R.,
Eisenstein, E. L., Shaw, L. J., Mark, D. B., Pritchett,
E. L. C., "Cost-Effectiveness of Inpatient
Initiation of Antiarrhythmic Therapy for Supraventricular
Tachycardias." American Journal of Cardiology
80:1551-1557 (1997). [61]
Stewart, A., Philips, R.J.M. and Dempsey, G. "Pharmacotherapy for
people with Alzheimers Disease: a Markov-cycle evaluation of
five years therapy using donepezil."
International Journal of Geriatric Psychiatry 13(7), 445-453 (1998) [62]
Thomas A. Gaziano, MD, MSc; Krisela Steyn, MSc, NED, MD; David J. Cohen, MD, MSc; Milton C. Weinstein, PhD; Lionel H. Opie, MD, DPhil, FRCP.
"Cost-Effectiveness Analysis of Hypertension Guidelines in South Africa: Absolute Risk Versus Blood Pressure Level"
Circulation. 2005; 112:3569-3576.
* link to PowerPoint presentation: http://www.globalhealth.harvard.edu/Files/Tom%20Gaziano.ppt
[96]
Wallace, Michael B., James Alan Kemp, Yvona M.
Trnka, Joanne M. Donovan, Francis A. Farraye. "Is Colonoscopy
Indicated for Small Adenomas Found by Screening Flexible
Sigmoidoscopy?" Ann Int Med 129:273-278 (1998) * link
to full-text: http://www.fsconsult.com/WebDoc/Sigmoid/index.html [63]
Witter, Morgan D., Gireesh V. Gupchup, Ernest J. Dole, Puneet Singhal, Amanda Beck.
"Pharmacoeconomic Assessment of Enoxaparin
in the Skilled Ward of a Long-Term Care
Facility versus Unfractionated Heparin in
the Hospital for Treatment of Proximal Deep Vein Thrombosis
."
Consult Pharm
15:151-9 (2000).
* link to full-text:
http://www.ascp.com/public/pubs/tcp/2000/feb/rr_pharm.shtml [65]
Yujin Hoshida, Hiratori, Yasushi, and Omata, Masao.
"Cost-effectiveness of adjuvant interferon therapy after surgical resection of Hepatitis C-related hepatocellular carcinoma."
Liver
22(6):479-85 (2002). [45]
Zanetti, Giorgio, Sue J. Goldie, and Richard Platt.
"Clinical Consequences and Cost of Limiting Use of Vancomycin for Perioperative Prophylaxis: Example of Coronary Artery Bypass Surgery."
Emerging Inf Dis (CDC)
7, 5 (2001).
* link to full-text:
http://www.cdc.gov/ncidod/eid/vol7no5/zanetti1.htm [66]
